| Oct 30 |
United Therapeutics: Q3 Earnings Snapshot
|
| Oct 30 |
United Therapeutics GAAP EPS of $6.39 misses by $0.03, revenue of $748.9M beats by $26.09M
|
| Oct 30 |
United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
|
| Oct 29 |
United Therapeutics Q3 2024 Earnings Preview
|
| Oct 29 |
Curious about United Therapeutics (UTHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics
|
| Oct 24 |
Earnings Preview: Ardelyx (ARDX) Q3 Earnings Expected to Decline
|
| Oct 23 |
United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
|
| Oct 23 |
United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
|
| Oct 18 |
Profitable Biotech In Buy Zone As Earnings Approach
|
| Oct 10 |
Peering Into United Therapeutics's Recent Short Interest
|
